{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:52:49Z","timestamp":1759009969290},"reference-count":64,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T00:00:00Z","timestamp":1084492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p>Anderson\u2013Fabry disease is an X\u2010linked recessive lysosomal storage disease resulting from deficient \u03b1\u2010galactosidase A activity. The conception of the disease has changed within the last decade. Studies of the last years have shown that the disease is not limited to the classical full\u2010blown manifestation in affected males, which is well known since more than a century, but may also occur in carrier females. The phenomenology may differ in severity and kind of organ manifestation. Cardiac and renal variants with solely disease manifestation of these organs have also been described in an increasing number. It is likely that a spectrum exists regarding \u03b1\u2010galactosidase A activity in both genders on the one hand, and an additional one regarding the severity and the number of organs affected on the other. The purpose of this review is to sharpen physicians\u2019 perception of this disease. Early and accurate diagnosis is mandatory considering that this disorder is now, after introduction of the novel enzyme replacement therapy, a treatable disease.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2004.01300.x","type":"journal-article","created":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T14:42:41Z","timestamp":1084545761000},"page":"629-636","source":"Crossref","is-referenced-by-count":21,"title":["The expanding clinical spectrum of Anderson\u2013Fabry disease: a challenge to diagnosis in the novel era of enzyme replacement therapy"],"prefix":"10.1111","volume":"255","author":[{"given":"A. C.","family":"Hauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sunder\u2010Plassmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,5,14]]},"reference":[{"key":"e_1_2_16_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"key":"e_1_2_16_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"e_1_2_16_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01986897"},{"key":"e_1_2_16_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1898.tb16317.x"},{"key":"e_1_2_16_6_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/clinchem\/13.7.565","article-title":"Enzymatic abnormalities in diseases of sphingolipid metabolism","volume":"13","author":"Brady RO.","year":"1967","journal-title":"Clin Chem"},{"key":"e_1_2_16_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.167.3922.1268"},{"key":"e_1_2_16_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-4-200302180-00014"},{"key":"e_1_2_16_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00160.x"},{"key":"e_1_2_16_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.249"},{"key":"e_1_2_16_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000016683.73778.78"},{"key":"e_1_2_16_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000015239.57436.18"},{"key":"e_1_2_16_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012993305223"},{"key":"e_1_2_16_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200203000-00003"},{"key":"e_1_2_16_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19970822)71:3<329::AID-AJMG14>3.0.CO;2-M"},{"key":"e_1_2_16_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.33.8.682"},{"key":"e_1_2_16_17_2","first-page":"227","article-title":"Fabry disease: twenty\u2010two novel mutations in the alpha\u2010galactosidase A gene and genotype\/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes","volume":"48","author":"Ashton\u2010Prolla P","year":"2000","journal-title":"J Invest Med"},{"key":"e_1_2_16_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990219)82:5<436::AID-AJMG14>3.0.CO;2-X"},{"key":"e_1_2_16_19_2","first-page":"2741","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Desnick RJ","year":"1995"},{"key":"e_1_2_16_20_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2003.00077.x"},{"key":"e_1_2_16_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2760(96)00175-0"},{"key":"e_1_2_16_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90062-4"},{"issue":"2","key":"e_1_2_16_23_2","first-page":"S126","article-title":"Anderson\u2010Fabry Disease: Its place among other genetic causes of renal disease","volume":"13","author":"Gr\u00fcnfeld JP","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_16_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6653.872"},{"key":"e_1_2_16_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03554-6"},{"key":"e_1_2_16_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.11.769"},{"key":"e_1_2_16_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780220715"},{"key":"e_1_2_16_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.4.347"},{"key":"e_1_2_16_29_2","doi-asserted-by":"publisher","DOI":"10.2190\/JKFW-3WXK-QA7N-BYLN"},{"key":"e_1_2_16_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(82)80262-X"},{"key":"e_1_2_16_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)44007-6"},{"key":"e_1_2_16_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.11.750"},{"key":"e_1_2_16_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-81-5-628"},{"key":"e_1_2_16_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1995.tb00161.x"},{"key":"e_1_2_16_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1991.tb03018.x"},{"key":"e_1_2_16_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000015238.98011.AF"},{"key":"e_1_2_16_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102073240607"},{"key":"e_1_2_16_38_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.105105"},{"key":"e_1_2_16_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450104"},{"key":"e_1_2_16_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000061952.27445.A0"},{"key":"e_1_2_16_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.68.9.323"},{"key":"e_1_2_16_42_2","first-page":"491","article-title":"The neurological complications of Anderson\u2010Fabry disease (alpha\u2010galactosidase A deficiency) \u2013 investigation of symptomatic and presymptomatic patients","volume":"75","author":"Morgan SH","year":"1990","journal-title":"Q J Med"},{"key":"e_1_2_16_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106640"},{"key":"e_1_2_16_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400105"},{"key":"e_1_2_16_45_2","article-title":"Results of an ophthalmologic screening program for identification of cases with Fabry disease","author":"Hauser AC","journal-title":"Ophthalmologica"},{"key":"e_1_2_16_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1979.01020010327008"},{"key":"e_1_2_16_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000016684.07368.75"},{"issue":"2","key":"e_1_2_16_48_2","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1097\/01.ASN.0000015237.87719.DC","article-title":"End\u2010stage renal disease in patients with Fabry disease","volume":"13","author":"Obrador GT","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_16_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg194"},{"key":"e_1_2_16_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s101570050061"},{"key":"e_1_2_16_51_2","first-page":"113","article-title":"Screening for Fabry disease in end\u2010stage nephropathies","volume":"25","author":"Spada M","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"e_1_2_16_52_2","unstructured":"WaltersBAJ PrichardM McCardleH RichardsSM BoschJP.Prevalence of reduced plasma \u03b1\u2010galactosidase activity in a cohort of male patients on hemodialysis (HO) in the United States.Genet Med2002;4:201."},{"key":"e_1_2_16_53_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.3.9116979"},{"key":"e_1_2_16_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90224-7"},{"key":"e_1_2_16_55_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s84.5.x"},{"key":"e_1_2_16_56_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014545521753"},{"key":"e_1_2_16_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/95.10.647"},{"key":"e_1_2_16_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03040321"},{"key":"e_1_2_16_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.1.7"},{"key":"e_1_2_16_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.1.33"},{"key":"e_1_2_16_61_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.8.819"},{"key":"e_1_2_16_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05816-0"},{"key":"e_1_2_16_63_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000091253.71282.04"},{"key":"e_1_2_16_64_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.222221899"},{"key":"e_1_2_16_65_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0537900100"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2004.01300.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2004.01300.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T19:20:47Z","timestamp":1697138447000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2004.01300.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,14]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1365-2796.2004.01300.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01300.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,14]]}}}